202 related articles for article (PubMed ID: 28007846)
1. Different origins of lysophospholipid mediators between coronary and peripheral arteries in acute coronary syndrome.
Kurano M; Kano K; Dohi T; Matsumoto H; Igarashi K; Nishikawa M; Ohkawa R; Ikeda H; Miyauchi K; Daida H; Aoki J; Yatomi Y
J Lipid Res; 2017 Feb; 58(2):433-442. PubMed ID: 28007846
[TBL] [Abstract][Full Text] [Related]
2. Blood levels of serotonin are specifically correlated with plasma lysophosphatidylserine among the glycero-lysophospholipids.
Kurano M; Dohi T; Nojiri T; Kobayashi T; Hirowatari Y; Inoue A; Kano K; Matsumoto H; Igarashi K; Nishikawa M; Miyauchi K; Daida H; Ikeda H; Aoki J; Yatomi Y
BBA Clin; 2015 Dec; 4():92-8. PubMed ID: 26675681
[TBL] [Abstract][Full Text] [Related]
3. Analysis of glycero-lysophospholipids in gastric cancerous ascites.
Emoto S; Kurano M; Kano K; Matsusaki K; Yamashita H; Nishikawa M; Igarashi K; Ikeda H; Aoki J; Kitayama J; Yatomi Y
J Lipid Res; 2017 Apr; 58(4):763-771. PubMed ID: 28143894
[TBL] [Abstract][Full Text] [Related]
4. Association between serum autotaxin or phosphatidylserine-specific phospholipase A1 levels and melanoma.
Kurano M; Miyagaki T; Miyagawa T; Igarashi K; Shimamoto S; Ikeda H; Aoki J; Sato S; Yatomi Y
J Dermatol; 2018 May; 45(5):571-579. PubMed ID: 29500864
[TBL] [Abstract][Full Text] [Related]
5. Possible involvement of minor lysophospholipids in the increase in plasma lysophosphatidic acid in acute coronary syndrome.
Kurano M; Suzuki A; Inoue A; Tokuhara Y; Kano K; Matsumoto H; Igarashi K; Ohkawa R; Nakamura K; Dohi T; Miyauchi K; Daida H; Tsukamoto K; Ikeda H; Aoki J; Yatomi Y
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):463-70. PubMed ID: 25425621
[TBL] [Abstract][Full Text] [Related]
6. [The Laboratory Medicine of Lipid Mediators].
Yatomi Y
Rinsho Byori; 2015 Oct; 63(10):1183-6. PubMed ID: 26897854
[TBL] [Abstract][Full Text] [Related]
7. Higher serum levels of autotaxin and phosphatidylserine-specific phospholipase A
Iwata Y; Kitajima S; Yamahana J; Shimomura S; Yoneda-Nakagawa S; Sakai N; Furuichi K; Ogura H; Sato K; Toyama T; Yamamura Y; Miyagawa T; Hara A; Shimizu M; Ohkawa R; Kurano M; Yatomi Y; Wada T
Int J Rheum Dis; 2021 Feb; 24(2):231-239. PubMed ID: 33314787
[TBL] [Abstract][Full Text] [Related]
8. Lysophospholipids in laboratory medicine.
Yatomi Y; Kurano M; Ikeda H; Igarashi K; Kano K; Aoki J
Proc Jpn Acad Ser B Phys Biol Sci; 2018; 94(10):373-389. PubMed ID: 30541965
[TBL] [Abstract][Full Text] [Related]
9. The binding of lysophospholipids to rat liver fatty acid-binding protein and albumin.
Thumser AE; Voysey JE; Wilton DC
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):801-6. PubMed ID: 8053904
[TBL] [Abstract][Full Text] [Related]
10. Phospholipase A1 Member A Activates Fibroblast-like Synoviocytes through the Autotaxin-Lysophosphatidic Acid Receptor Axis.
Zhao Y; Hasse S; Vaillancourt M; Zhao C; Davis L; Boilard E; Fortin P; Di Battista J; Poubelle PE; Bourgoin SG
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884486
[TBL] [Abstract][Full Text] [Related]
11. Possible involvement of PS-PLA1 and lysophosphatidylserine receptor (LPS1) in hepatocellular carcinoma.
Uranbileg B; Kurano M; Sato M; Ikeda H; Ishizawa T; Hasegawa K; Kokudo N; Yatomi Y
Sci Rep; 2020 Feb; 10(1):2659. PubMed ID: 32060356
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Dysregulation of the Lysophospholipid/Autotaxin Axis in the Chromosome 9p21 Gene SNP rs10757274.
Meckelmann SW; Hawksworth JI; White D; Andrews R; Rodrigues P; O'Connor A; Alvarez-Jarreta J; Tyrrell VJ; Hinz C; Zhou Y; Williams J; Aldrovandi M; Watkins WJ; Engler AJ; Lo Sardo V; Slatter DA; Allen SM; Acharya J; Mitchell J; Cooper J; Aoki J; Kano K; Humphries SE; O'Donnell VB
Circ Genom Precis Med; 2020 Jun; 13(3):e002806. PubMed ID: 32396387
[TBL] [Abstract][Full Text] [Related]
13. Understanding modulations of lipid mediators in cancer using a murine model of carcinomatous peritonitis.
Kurano M; Sakai E; Yatomi Y
Cancer Med; 2022 Sep; 11(18):3491-3507. PubMed ID: 35315587
[TBL] [Abstract][Full Text] [Related]
14. Increased lysophosphatidic acid levels in culprit coronary arteries of patients with acute coronary syndrome.
Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Kurano M; Kishimoto T; Yanagisawa N; Ogita M; Miyazaki T; Nishino A; Yaginuma K; Tamura H; Kojima T; Yokoyama K; Kurata T; Shimada K; Daida H; Yatomi Y
Atherosclerosis; 2013 Jul; 229(1):192-7. PubMed ID: 23664202
[TBL] [Abstract][Full Text] [Related]
15. Role of the placenta in serum autotaxin elevation during maternal cholestasis.
Macias RIR; Matilla S; Lozano E; Estiú MC; Oude Elferink RP; Marin JJG
Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G399-G407. PubMed ID: 29927323
[TBL] [Abstract][Full Text] [Related]
16. Elevated phosphatidylserine-specific phospholipase A1 level in hyperthyroidism.
Nakawatari K; Kurano M; Araki O; Nishikawa M; Shimamoto S; Igarashi K; Aoki J; Murakami M; Yatomi Y
Clin Chim Acta; 2020 Apr; 503():99-106. PubMed ID: 31978406
[TBL] [Abstract][Full Text] [Related]
17. The activities of acyl-CoA:1-acyl-lysophospholipid acyltransferase(s) in human platelets.
Bakken AM; Farstad M
Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):763-70. PubMed ID: 1471991
[TBL] [Abstract][Full Text] [Related]
18. Measurement of plasma choline in acute coronary syndrome: importance of suitable sampling conditions for this assay.
Ohkawa R; Kurano M; Sakai N; Kishimoto T; Nojiri T; Igarashi K; Hosogaya S; Ozaki Y; Dohi T; Miyauchi K; Daida H; Aoki J; Okubo S; Ikeda H; Tozuka M; Yatomi Y
Sci Rep; 2018 Mar; 8(1):4725. PubMed ID: 29549312
[TBL] [Abstract][Full Text] [Related]
19. Evidence for two distinct lysophospholipase activities that degrade lysophosphatidylcholine and lysophosphatidic acid in neuronal nuclei of cerebral cortex.
Baker RR; Chang HY
Biochim Biophys Acta; 1999 May; 1438(2):253-63. PubMed ID: 10320808
[TBL] [Abstract][Full Text] [Related]
20. Current Knowledge on Mammalian Phospholipase A
Yaginuma S; Kawana H; Aoki J
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
